查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1433328

2023-2030 年全球無引線心律調節器市場

Global Leadless Pacemakers Market 2023-2030
出版日期: | 出版商: Orion Market Research | 英文 175 Pages | 商品交期: 2-3個工作天內

價格

預計在預測期內（2023-2030 年），全球無引線心律調節器市場將以 3.6% 的CAGR成長。主要因素之一歸因於市場成長，包括老年人口的增加、心血管疾病（CVD）盛行率的增加、有利的政府舉措和政策以及新型和增強型技術產品的推出。據世界衛生組織稱，2019 年估計有 1,790 萬人死於心血管疾病，佔全球死亡率的 32%。此外，2022 年 11 月，《老年人口統計：美國老化肖像》一文報道，有 5,410 萬名成年人（占美國人口的 16.3%）是老年人，其中包括 65 歲或以上的老年人。預計到 2040 年，老年人口將增加至 22%，到 2060 年將增加至 25%。此外，越來越多的產品推出以滿足對無引線起搏器的需求。 2023 年 9 月，Beebe Healthcare 推出了無引線心律調節器，並成為特拉華州第一家植入該設備的公司。特拉華州第一位接受 Micra AV2 無引線起搏器的心臟病患者在 Beebe 接受微創植入手術就是一個例證。

區隔市場前景

全球無引線心律調節器市場依起搏室、產品和最終用途進行區隔。根據起搏室，市場分為單室和雙室。根據產品，市場區隔為 micra 經導管起搏系統和 nanostim 無引線心律調節器。此外，根據最終用途，市場區隔為醫院、門診手術中心等。其他包括心臟中心。在最終用途中，預計醫院區隔市場將在預測期內佔據最大的市場佔有率。該區隔市場的大部分佔有率歸功於較低的成本、較高的效率和可用性。

Micra 經導管起搏系統區隔市場預計將在全球無引線起搏器市場中佔據相當大的佔有率

在這些產品中，Micra 經導管起搏系統區隔市場預計將在預測期內成長。 Micra 是一種單腔心律調節器，其大小與維生素一樣，可以直接植入心臟，無需植入導線。此區隔市場的推動因素是心血管疾病負擔日益增加、植入後併發症極少以及易於取出，預計將刺激市場。英國心臟基金會（BHF）2023年1月公佈的資料報告稱，2021年最常見的心血管疾病是冠心病（缺血性）心臟病（2019年全球患病率估計為2億）、外周動脈（血管）疾病（1.1億） 、中風（1億）和心房顫動（6000萬）。此外，報告也顯示，北美心臟和循環系統疾病盛行率為4,800萬，歐洲為1億，非洲和中東為9,800萬，拉丁美洲為4,800萬，亞洲和澳洲為是3.4億。此外，核准的增加也擴大了有資格接受 Micra TPS 的患者數量。例如，2022 年 1 月，醫療保健技術先驅美敦力公司 (Medtronic plc) 獲得日本厚生勞動省批准銷售 Micra (TM) AV 經導管起搏系統並獲得報銷。

區域展望

全球無引線心律調節器市場根據地理位置進一步區隔，包括北美（美國和加拿大）、歐洲（英國、義大利、西班牙、德國、法國和歐洲其他地區）、亞太地區（印度、中國、日本） 、韓國和亞洲其他地區）以及世界其他地區（中東和非洲以及拉丁美洲）。其中，由於對無引線起搏器的需求不斷成長，預計歐洲在預測期內將出現成長，老年人口、心血管疾病患病率的增加、醫療保健支出的增加，推動了歐洲無引線心律調節器市場的發展。

北美地區預計全球無引線起搏器市場將以顯著的複合CAGR成長

預計在預測期內，北美將在無引線起搏器市場中佔據顯著佔有率。推動北美市場的重要因素是整個北美 CVD 數量的不斷增加，預計這將對未來幾年無引線起搏器市場的成長產生積極影響。根據美國心臟協會的數據，心血管疾病仍然是美國的首要死因，2020 年導致 928,741 人死亡。此外，心臟相關疾病數量的增加和技術進步進一步推動了該地區的市場。 2020 年，在美國，冠狀動脈心臟病 (CHD) 是美國 CVD 死亡的主要原因 (41.2%)，其次是中風 (17.3%)、其他 CVD (16.8%)、高血壓 (12.9%) ）、心臟衰竭（9.2 %）。

市場參與者展望

服務於無引線起搏器市場的主要公司包括 Abbott Laboratories、Medtronic PLC、Boston Scientific Corp.、MicroPort Scientific Corp. 等。市場參與者透過各種策略（包括併購、合作、合作、融資和新產品發布），為市場成長做出了巨大貢獻，以保持市場競爭力。例如，2022年10月，Ceryx Medical Ltd與Osypka Medical合作開發心臟節律設備。 Ceryx 和 Osypka 開發了一種心臟起搏裝置，改變了心臟衰竭和其他心臟病患者的治療方式。

報告涵蓋：

  • 2022年市場價​​值資料分析及2030年預測。
  • 每個區隔市場的年化市場收入（百萬美元）。
  • 主要地理區域的國家分析。
  • 全球無引線起搏器市場的主要公司。根據現有資料，報告中還提供了與新產品發布相關的資訊以及相關新聞。
  • 透過確定未來強勁成長的關鍵區隔市場來分析業務策略。
  • 市場進入和市場擴張策略分析。
  • 透過識別市場中「誰的立場」來制定競爭策略。

目錄

第 1 章：報告摘要

  • 目前行業分析及成長潛力展望
  • 研究方法和工具
  • 市場區隔
    • 依區隔
    • 依地區

第 2 章：市場概述與見解

  • 報告範圍
  • 分析師見解和當前市場趨勢
    • 主要發現
    • 建議
    • 結論

第 3 章：競爭格局

  • 主要公司分析
  • Abbott Laboratories
    • 概述
    • 財務分析
    • SWOT分析
    • 最近的發展
  • Boston Scientific Corp.
    • 概述
    • 財務分析
    • SWOT分析
    • 最近的發展
  • Medtronic plc
    • 概述
    • 財務分析
    • SWOT分析
    • 最近的發展
  • MicroPort Scientific Corp.
    • 概述
    • 財務分析
    • SWOT分析
    • 最近的發展
  • 關鍵策略分析

第 4 章：市場區隔

  • 依起搏室分類的全球無引線心律調節器市場
    • 單室
    • 雙室
  • 依產品分類的全球無引線心律調節器市場
    • Micra 經導管心律調節系統
    • Nanostim 無引線心律調節器
  • 依最終用途分類的全球無引線心律調節器市場
    • 醫院
    • 門診手術中心
    • 其他（心臟中心）

第 5 章：區域分析

  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 英國
    • 德國
    • 義大利
    • 西班牙
    • 法國
    • 歐洲其他地區
  • 亞太
    • 中國
    • 印度
    • 日本
    • 韓國
    • 亞太其他地區
  • 世界其他地區

第 6 章：公司簡介

  • BIOTRONIK SE & Co KG
  • Beebe Healthcare
  • EBR Systems Inc.,
  • Lepu Medical Technology(Beijing)Co.,Ltd.
  • LivaNova PLC
  • OSYPKA MEDICAL GmbH
  • Telectronics Pacing Systems, Inc.
  • Terumo Corp.
Product Code: OMR2028005

Global Leadless Pacemakers Market Size, Share & Trends Analysis Report by Pacing Chamber (Single-chamber Pacemaker, Dual-chamber Pacemaker), By Product, (Micra Transcatheter Pacing System and Nanostim Leadless Pacemaker), by End-Use (Hospitals, Ambulatory Surgical Centers, and Others), Forecast Period (2023-2030)

The global leadless pacemakers market is anticipated to grow at a CAGR of 3.6% during the forecast period (2023-2030). One of the major factors are attributed to the market growth including the rising geriatric population, increasing prevalence of cardiovascular disease (CVDs), favorable government initiatives and policies, and the introduction of new and enhanced technological products. According to the World Health Organization, an estimated 17.9 million people died from CVDs in 2019, representing 32% of all global mortalities. Further, in November 2022, the article "Senior Population Statistics: A Portrait of Aging Americans", reported 54.1 million adults or 16.3% of the US population are seniors including aged 65 or older. The senior population is expected to rise to 22% by 2040 and 25% by 2060. In addition, the increasing products launches to cater the demand for leadless pacemakers. In September 2023, Beebe Healthcare introduced leadless pacemaker and becomes first in Delaware to implant the device. That was exemplified when the first cardiac patient in Delaware to receive the Micra AV2 leadless pacemaker underwent the minimally invasive implantation procedure at Beebe.

Segmental Outlook

The global leadless pacemakers market is segmented by pacing chamber, product, and end-use. Based on the pacing chamber, the market is sub-segmented into single chamber, and dual chamber. Based on the product, the market is sub-segmented into micra transcatheter pacing system and nanostim leadless pacemaker. Further, based on end-use, the market is sub-segmented into hospitals, ambulatory surgical centers, and others. Where others include cardiac centers. Among the end-use, the hospitals sub-segment is anticipated to hold the largest market share during the forecast period. The large share of this segment is credited to the lower costs, higher efficiency, and availability.

The Micra Transcatheter Pacing System Sub-Segment is Anticipated to Hold a Considerable Share of the Global Leadless Pacemakers Market

Among the products, micra transcatheter pacing system sub-segment expected to grow over the forecast period. Micra is a single-chamber pacemaker specifically the size of a vitamin and can be implanted directly into the heart, eliminating the need for the leads to be implanted. The segment is driven by the owing to the increasing burden of CVDs, minimal post-implantation complications, and easy retrieval, which is projected to encourage the market. The British Heart Foundation (BHF) data published in January 2023 reported that in 2021, the most common cardiovascular conditions are coronary (ischaemic) heart disease (global prevalence estimated at 200 million in 2019), peripheral arterial (vascular) disease (110 million), stroke (100 million) and atrial fibrillation (60 million). Additionally, the report revealed that the prevalence of heart and circulatory diseases in North America was 48 million, in Europe it was 100 million, in Africa and middle east it was 98 million, in Latin America it was 48 million, and in Asia and Australia it was 340 million. Furthermore, the increasing approvals expands the number of patients who are eligible to receive the Micra TPS. For instance, in January 2022, Medtronic plc, a pioneer in healthcare technology, received approval from Japan's Ministry of Health, Labor and Welfare for the sale and reimbursement of the Micra™ AV transcatheter pacing system.

Regional Outlook

The global leadless pacemakers market is further segmented based on geography including North America (the US, and Canada), Europe (UK, Italy, Spain, Germany, France, and the Rest of Europe), Asia-Pacific (India, China, Japan, South Korea, and Rest of Asia), and the Rest of the World (the Middle East & Africa, and Latin America. Among these, Europe is anticipated to grow over the forecast period, owing to the growing demand for leadless pacemakers, increasing geriatric population, , increasing prevalence of CVDs, the rising healthcare expenditure, driving the leadless pacemakers market in the Europe.

The North America Region is Expected to Grow at a Significant CAGR in the Global Leadless Pacemakers Market

North America is expected to hold a prominent share in the leadless pacemakers market during the forecast period. The significant factors fueling the North America market is the rising number of CVDs across the North America is estimated to positively impact the leadless pacemakers market growth in upcoming years. According to the American Heart Association, CVDs remains as the leading cause of death in the US, accounted for 928,741 deaths in the year 2020. Additionally, the increasing number of heart-related disorders and technological advancements are further driving the market in the region. In 2020 in the US, coronary heart disease (CHD) was the leading cause (41.2%) of deaths attributable to CVD in the US, followed by stroke (17.3%), other CVD (16.8%), high blood pressure (12.9%), heart failure (9.2%).

Market Players Outlook

The major companies serving the leadless pacemakers market include Abbott Laboratories, Medtronic PLC, Boston Scientific Corp., MicroPort Scientific Corp., and others. The market players are considerably contributing to the market growth by the adoption of various strategies including mergers and acquisitions, partnerships, collaborations, funding, and new product launches, to stay competitive in the market. For instance, in October 2022, Ceryx Medical Ltd, partnered with Osypka medical to develop heart pacing device. Ceryx and Osypka developed a heart pacing device that changed the way patients with heart failure and other cardiac conditions are treated.

The Report Covers:

  • Market value data analysis of 2022 and forecast to 2030.
  • Annualized market revenues ($ million) for each market segment.
  • Country-wise analysis of major geographical regions.
  • Key companies operating in the global leadless pacemakers market. Based on the availability of data, information related to new product launches, and relevant news is also available in the report.
  • Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
  • Analysis of market-entry and market expansion strategies.
  • Competitive strategies by identifying 'who-stands-where' in the market.

Table of Contents

1. Report Summary

  • Current Industry Analysis and Growth Potential Outlook
  • 1.1. Research Methods and Tools
  • 1.2. Market Breakdown
    • 1.2.1. By Segments
    • 1.2.2. By Region

2. Market Overview and Insights

  • 2.1. Scope of the Report
  • 2.2. Analyst Insight & Current Market Trends
    • 2.2.1. Key Findings
    • 2.2.2. Recommendations
    • 2.2.3. Conclusion

3. Competitive Landscape

  • 3.1. Key Company Analysis
  • 3.2. Abbott Laboratories
    • 3.2.1. Overview
    • 3.2.2. Financial Analysis
    • 3.2.3. SWOT Analysis
    • 3.2.4. Recent Developments
  • 3.3. Boston Scientific Corp.
    • 3.3.1. Overview
    • 3.3.2. Financial Analysis
    • 3.3.3. SWOT Analysis
    • 3.3.4. Recent Developments
  • 3.4. Medtronic plc
    • 3.4.1. Overview
    • 3.4.2. Financial Analysis
    • 3.4.3. SWOT Analysis
    • 3.4.4. Recent Developments
  • 3.5. MicroPort Scientific Corp.
    • 3.5.1. Overview
    • 3.5.2. Financial Analysis
    • 3.5.3. SWOT Analysis
    • 3.5.4. Recent Developments
  • 3.6. Key Strategy Analysis

4. Market Segmentation

  • 4.1. Global Leadless Pacemakers Market by Pacing Chamber
    • 4.1.1. Single Chamber
    • 4.1.2. Dual Chamber
  • 4.2. Global Leadless Pacemakers Market by Product
    • 4.2.1. Micra Transcatheter Pacing System
    • 4.2.2. Nanostim Leadless Pacemaker
  • 4.3. Global Leadless Pacemakers Market by End-Use
    • 4.3.1. Hospitals
    • 4.3.2. Ambulatory Surgical Centers
    • 4.3.3. Other (Cardiac Centers)

5. Regional Analysis

  • 5.1. North America
    • 5.1.1. United States
    • 5.1.2. Canada
  • 5.2. Europe
    • 5.2.1. UK
    • 5.2.2. Germany
    • 5.2.3. Italy
    • 5.2.4. Spain
    • 5.2.5. France
    • 5.2.6. Rest of Europe
  • 5.3. Asia-Pacific
    • 5.3.1. China
    • 5.3.2. India
    • 5.3.3. Japan
    • 5.3.4. South Korea
    • 5.3.5. Rest of Asia-Pacific
  • 5.4. Rest of the World

6. Company Profiles

  • 6.1. BIOTRONIK SE & Co KG
  • 6.2. Beebe Healthcare
  • 6.3. EBR Systems Inc.,
  • 6.4. Lepu Medical Technology(Beijing)Co.,Ltd.
  • 6.5. LivaNova PLC
  • 6.6. OSYPKA MEDICAL GmbH
  • 6.7. Telectronics Pacing Systems, Inc.
  • 6.8. Terumo Corp.

LIST OF TABLES

  • 1. GLOBAL LEADLESS PACEMAKERS MARKET RESEARCH AND ANALYSIS BY PACING CHAMBER, 2022-2030 ($ MILLION)
  • 2. GLOBAL SINGLE CHAMBER LEADLESS PACEMAKER MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 3. GLOBAL DUAL CHAMBER LEADLESS PACEMAKER MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 4. GLOBAL LEADLESS PACEMAKERS MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2022-2030 ($ MILLION)
  • 5. GLOBAL MICRA TRANSCATHETER PACING SYSTEM MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 6. GLOBAL NANOSTIM LEADLESS PACEMAKER MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 7. GLOBAL LEADLESS PACEMAKERS MARKET RESEARCH AND ANALYSIS BY END-USE, 2022-2030 ($ MILLION)
  • 8. GLOBAL LEADLESS PACEMAKERS FOR HOSPITALS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 9. GLOBAL LEADLESS PACEMAKERS FOR AMBULATORY SURGICAL CENTERS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 10. GLOBAL LEADLESS PACEMAKERS FOR OTHER END-USE MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 11. GLOBAL LEADLESS PACEMAKERS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 12. NORTH AMERICAN LEADLESS PACEMAKERS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 13. NORTH AMERICAN LEADLESS PACEMAKERS MARKET RESEARCH AND ANALYSIS BY PACING CHAMBER, 2022-2030 ($ MILLION)
  • 14. NORTH AMERICAN LEADLESS PACEMAKERS MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2022-2030 ($ MILLION)
  • 15. NORTH AMERICAN LEADLESS PACEMAKERS MARKET RESEARCH AND ANALYSIS BY END-USE, 2022-2030 ($ MILLION)
  • 16. EUROPEAN LEADLESS PACEMAKERS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 17. EUROPEAN LEADLESS PACEMAKERS MARKET RESEARCH AND ANALYSIS BY PACING CHAMBER, 2022-2030 ($ MILLION)
  • 18. EUROPEAN LEADLESS PACEMAKERS MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2022-2030 ($ MILLION)
  • 19. EUROPEAN LEADLESS PACEMAKERS MARKET RESEARCH AND ANALYSIS BY END-USE, 2022-2030 ($ MILLION)
  • 20. ASIA-PACIFIC LEADLESS PACEMAKERS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 21. ASIA-PACIFIC LEADLESS PACEMAKERS MARKET RESEARCH AND ANALYSIS BY PACING CHAMBER, 2022-2030 ($ MILLION)
  • 22. ASIA-PACIFIC LEADLESS PACEMAKERS MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2022-2030 ($ MILLION)
  • 23. ASIA-PACIFIC LEADLESS PACEMAKERS MARKET RESEARCH AND ANALYSIS BY END-USE, 2022-2030 ($ MILLION)
  • 24. REST OF THE WORLD LEADLESS PACEMAKERS MARKET RESEARCH AND ANALYSIS BY PACING CHAMBER, 2022-2030 ($ MILLION)
  • 25. REST OF THE WORLD LEADLESS PACEMAKERS MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2022-2030 ($ MILLION)
  • 26. REST OF THE WORLD LEADLESS PACEMAKERS MARKET RESEARCH AND ANALYSIS BY END-USE, 2022-2030 ($ MILLION)

LIST OF FIGURES

  • 1. GLOBAL LEADLESS PACEMAKERS MARKET SHARE BY PACING CHAMBER, 2022 VS 2030 (%)
  • 2. GLOBAL SINGLE CHAMBER LEADLESS PACEMAKER MARKET SHARE, 2022 VS 2030 (%)
  • 3. GLOBAL DUAL CHAMBER LEADLESS PACEMAKER MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 4. GLOBAL LEADLESS PACEMAKERS MARKET SHARE BY PRODUCT, 2022 VS 2030 (%)
  • 5. GLOBAL MICRA TRANSCATHETER PACING SYSTEM MARKET SHARE, 2022 VS 2030 (%)
  • 6. GLOBAL NANOSTIM LEADLESS PACEMAKER MARKET SHARE, 2022 VS 2030 (%)
  • 7. GLOBAL LEADLESS PACEMAKERS MARKET RESEARCH AND ANALYSIS BY END-USE, 2022 VS 2030 (%)
  • 8. GLOBAL LEADLESS PACEMAKERS FOR HOSPITALS MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 9. GLOBAL LEADLESS PACEMAKERS FOR AMBULATORY SURGICAL CENTERS MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 10. GLOBAL LEADLESS PACEMAKERS FOR OTHER APPLICATION MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 11. GLOBAL LEADLESS PACEMAKERS MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 12. US LEADLESS PACEMAKERS MARKET SIZE, 2022-2030 ($ MILLION)
  • 13. CANADA LEADLESS PACEMAKERS MARKET SIZE, 2022-2030 ($ MILLION)
  • 14. UK LEADLESS PACEMAKERS MARKET SIZE, 2022-2030 ($ MILLION)
  • 15. FRANCE LEADLESS PACEMAKERS MARKET SIZE, 2022-2030 ($ MILLION)
  • 16. GERMANY LEADLESS PACEMAKERS MARKET SIZE, 2022-2030 ($ MILLION)
  • 17. ITALY LEADLESS PACEMAKERS MARKET SIZE, 2022-2030 ($ MILLION)
  • 18. SPAIN LEADLESS PACEMAKERS MARKET SIZE, 2022-2030 ($ MILLION)
  • 19. REST OF EUROPE LEADLESS PACEMAKERS MARKET SIZE, 2022-2030 ($ MILLION)
  • 20. INDIA LEADLESS PACEMAKERS MARKET SIZE, 2022-2030 ($ MILLION)
  • 21. CHINA LEADLESS PACEMAKERS MARKET SIZE, 2022-2030 ($ MILLION)
  • 22. JAPAN LEADLESS PACEMAKERS MARKET SIZE, 2022-2030 ($ MILLION)
  • 23. SOUTH KOREA LEADLESS PACEMAKERS MARKET SIZE, 2022-2030 ($ MILLION)
  • 24. REST OF ASIA-PACIFIC LEADLESS PACEMAKERS MARKET SIZE, 2022-2030 ($ MILLION)
  • 25. REST OF THE WORLD LEADLESS PACEMAKERS MARKET SIZE, 2022-2030 ($ MILLION)